S&P 500
5.291,34 +7,94 (+0,15%) Nasdaq
16.857,05 +28,38 (+0,17%) NIKKEI 225
38.837,46 -85,54 (-0,22%) Dólar/Euro
1,0884 -0,0023 (-0,21%) Petróleo Brent
77,22 -1,14 (-1,45%) Bitcoin EUR
64.776,31 +1.244,66 (+1,96%)
Polarean Imaging plc (POLX.L)
Polarean Imaging plc
2500 Meridian Pkwy
Suite 175
Durham, NC 27713
United States
https://polarean.com
Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 28
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Kenneth Paul West | Chairman of the Board | 44,53k | N/A | 1957 |
| Dr. Bastiaan Driehuys Ph.D. | Founder, Chief Scientific Officer & Director | 28,64k | N/A | 1970 |
| Mr. Charles Fremont Osborne Jr. | CFO & Director | 268,45k | N/A | 1966 |
| Dr. Christopher Richard Von Jako Ph.D. | CEO & Director | N/A | N/A | 1970 |
| Mr. Neil Wadehra | Vice President of Operations | N/A | N/A | 1980 |
| Mr. Alex Dusek | Chief Commercial Officer | N/A | N/A | 1967 |
| Mr. Stephen Austin | Company Secretary | N/A | N/A | N/A |
Descripción
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polarizer devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.
Gobierno corporativo
El ISS Governance QualityScore de Polarean Imaging plc, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
